ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/02/2025
Voltar para busca
Dado oficial do USPTO
PS PS128
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
37
Atualização mais recente
12/02/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 29
Data de depósito
18/01/2022
Data de registro
14/05/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/05/2024
Última transação
12/02/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
98
Localização do titular
CN
Examinador
WOLD, BARBARA
Unidade examinadora
M50
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the stylized wording "PS" and stylized "PS128".
Titulares e representantes
Titulares
Bened Biomedical Co., Ltd.
Bened Biomedical Co.,Ltd.
Representantes
Yue (Robert) Xu Apex Attorneys at Law, LLP
Classificação técnica
Classes Nice
Classe 5Classe 29
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical agents affecting peripheral nervous system made in whole or substantial part of Lactobacillus plantarum PS128; pharmaceutical preparations acting on the central nervous system made in whole or substantial part of Lactobacillus plantarum PS128; medicated candies made in whole or substantial part of Lactobacillus plantarum PS128; dietetic foods adapted for medical use made in whole or substantial part of Lactobacillus plantarum PS128; biological preparations for veterinary purposes made in whole or substantial part of Lactobacillus plantarum PS128 for the treatment of separation anxietyaggressioncompulsive disorderexcessive barkingyowl and stabilize emotional status; Preparations of microorganisms for medical or veterinary use made in whole or substantial part of Lactobacillus plantarum PS128 for the treatment of autism spectrum disorderParkinson's diseaseAlzheimer's diseasedepressive disorderTourette syndromevisceral hypersensitivityconstipationinsomniastressseparation anxietyaggressioncompulsive disorderexcessive barkingyowl and stabilize emotional status; nutraceutical preparations for therapeutic or medical purposes made in whole or substantial part of Lactobacillus plantarum PS128 for the treatment of autism spectrum disorderParkinson's diseaseAlzheimer's diseasedepressive disorderTourette syndromevisceral hypersensitivityconstipationinsomniastress; milk ferments for pharmaceutical purposes made in whole or substantial part of Lactobacillus plantarum PS128; biological preparations for medical purposes made in whole or substantial part of Lactobacillus plantarum PS128 for the treatment of autism spectrum disorderParkinson's diseaseAlzheimer's diseasedepressive disorderTourette syndromevisceral hypersensitivityconstipationinsomniastress; powdered whey proteins being nutritional supplements made in whole or substantial part of Lactobacillus plantarum PS128
Classe 29
Yogurt made in whole or substantial part of Lactobacillus plantarum PS128; whey made in whole or substantial part of Lactobacillus plantarum PS128; milk products made in whole or substantial part of Lactobacillus plantarum PS128 namelymilk-based nutritional supplement drinks; milk ferments for culinary purposes made in whole or substantial part of Lactobacillus plantarum PS128; powdered milk made in whole or substantial part of Lactobacillus plantarum PS128; beverages having a milk base made in whole or substantial part of Lactobacillus plantarum PS128; yogurt drinks made in whole or substantial part of Lactobacillus plantarum PS128; milk solids made in whole or substantial part of Lactobacillus plantarum PS128
Publicações
Histórico de despachos e eventos da marca no USPTO.
37 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
30/11/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/11/2024
FIMP
FINAL DISPOSITION PROCESSED
07/11/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
14/08/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
14/05/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
14/05/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/03/2024
PUBO
PUBLISHED FOR OPPOSITION
27/02/2024
GPNX
NOTIFICATION PROCESSED BY IB
26/02/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/02/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/02/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/02/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/01/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
18/01/2024
DOCK
ASSIGNED TO EXAMINER
12/01/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
25/12/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/12/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
06/12/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
21/07/2023
GNFR
FINAL REFUSAL E-MAILED
21/07/2023
CNFR
FINAL REFUSAL WRITTEN
21/07/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/07/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/07/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/07/2023
RFNP
REFUSAL PROCESSED BY IB
07/02/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
18/01/2023
RFRR
REFUSAL PROCESSED BY MPU
17/01/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/11/2022
CNRT
NON-FINAL ACTION WRITTEN
03/11/2022
DOCK
ASSIGNED TO EXAMINER
27/10/2022
MAFR
APPLICATION FILING RECEIPT MAILED
05/07/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/07/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
30/06/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PS PS128 ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.